Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Desogestrel 0.075 mg Tablets
NCT04422028Phase 1Completed
- Sponsor
- Laboratorios Andromaco S.A.
- Start
- Jan 2020
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of desogestrel in contraception (2 arms), sponsored by Laboratorios Andromaco S.A. Primary endpoints: Area under the plasma concentration-time curve from time zero to 72 hours, Area under the plasma concentration-time curve from time zero to time t and 2 more. Started Jan 2020; status: completed.
02
Drugs
desogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04422028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04422028.